EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomics in Chronic Kidney Diseases: Here to Stay

Mihaela-Roxana Pătruică, Florica Gădălean, Adrian Vlad, Adrian Sturza, Dragos Cătălin Jianu, Lavinia Balint, Silvia Ienciu, Ligia Petrica, Danina M. Muntean, Carmen Socaciu

Timisoara Medical Journal · 16.02.2021 · 2020 (2) · 1

DOI: 10.35995/tmj20200208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Timisoara Medical Journal, online erschienen am 16.02.2021. Verfasst von Mihaela-Roxana Pătruică und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) affects around 13% of the adult population, has become a considerable concern worldwide, and is characterized by inadequate renal clearance, resulting in the accumulation of various potential toxic compounds. Metabolomics, one of the many important parts of “omics” science, refers to the systematic study of metabolites in a living system and their changes because of pathophysiological and genetic modifications. The use of metabolomics in the nephrology field of research has offered a better understanding of the pathomechanisms of CKD. The most recent technologies used for the evaluation of plasma and urinary metabolites are nuclear magnetic resonance (NMR) and mass spectroscopy (MS). A major research direction of modern medicine is to develop new therapies and new biomarkers for the early diagnosis of patients with CKD. Experimental studies of renal metabolism unequivocally demonstrated that kidney function has a huge impact on several circulating metabolites. Moreover, metabolites themselves appear to have an essential role in CKD pathogenesis/complications, being recognized as potential biomarkers with prognostic, diagnostic, and therapeutic value for the disease. The present paper provides a bird’s eye view on metabolomics and a summary of the most recent studies of metabolomics carried out in patients with CKD.

Zitieren

APA

Pătruică, M., Gădălean, F., Vlad, A., Sturza, A., Jianu, D. C., Balint, L., Ienciu, S., Petrica, L., Muntean, D. M., & Socaciu, C. (2021). Metabolomics in Chronic Kidney Diseases: Here to Stay. Timisoara Medical Journal, 2020(2), 1. https://doi.org/10.35995/tmj20200208

Vancouver

Pătruică M, Gădălean F, Vlad A, Sturza A, Jianu DC, Balint L, et al. Metabolomics in Chronic Kidney Diseases: Here to Stay. Timisoara Medical Journal. 2021;2020(2):1. doi:10.35995/tmj20200208

BibTeX
@article{Ptruic2021,
  author = {Pătruică, Mihaela-Roxana and Gădălean, Florica and Vlad, Adrian and Sturza, Adrian and Jianu, Dragos Cătălin and Balint, Lavinia and Ienciu, Silvia and Petrica, Ligia and Muntean, Danina M. and Socaciu, Carmen},
  title = {Metabolomics in Chronic Kidney Diseases: Here to Stay},
  journal = {Timisoara Medical Journal},
  year = {2021},
  volume = {2020},
  number = {2},
  pages = {1},
  doi = {10.35995/tmj20200208}
}
Kostenlos starten →